Arteris Inc (AIP)
🔔 Watch stock
Appears in These Scanners
This stock currently matches 23 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Basics
Performance
Valuation
Profitability
Balance Sheet & Safety
Growth
Quality & Screener
AI Rating
Sells AIArteris lizenziert Network-on-Chip-Verbindungstechnik (NoC) ausdrücklich auch für KI-Chips: Der Geschäftsbericht (10-K) nennt KI/Machine Learning als Endmarkt des Lizenz- und Royalty-Umsatzes, beschreibt KI als Beschleuniger des NoC-Geschäfts, das Produkt FlexGen arbeitet mit KI-gestützter Automatisierung — und die Filings warnen, dass Exportkontrollen auf KI-Chipdesigner in China den eigenen Umsatz senken können.
View the full file — quotes, sources, reviewed filings
„Artificial Intelligence (AI) and Generative AI are transforming the semiconductor industry, revolutionizing how our customers approach design, development, and the resulting products. The rapid expansion of AI applications across various industries, combined with the increasing complexity of electronic system design, is accelerating the use of network-on-chip technologies."
Künstliche Intelligenz (KI) und generative KI transformieren die Halbleiterindustrie und revolutionieren, wie unsere Kunden Design, Entwicklung und die daraus entstehenden Produkte angehen. Die rasche Ausbreitung von KI-Anwendungen über verschiedenste Branchen hinweg beschleunigt — zusammen mit der wachsenden Komplexität des Elektronik-Designs — den Einsatz von Network-on-Chip-Technologien.
„Demand for our interconnect IP solutions and associated royalty revenue is highly dependent on market conditions in the end markets in which our customers operate. These end markets, which include the automotive, enterprise computing, communications, artificial intelligence and machine learning, consumer electronics, and industrial markets, are subject to a number of factors including end-product acceptance and sales, competitive pressures, supply chain issues and general market conditions."
Die Nachfrage nach unseren Interconnect-IP-Lösungen und der zugehörige Royalty-Umsatz hängen stark von den Marktbedingungen in den Endmärkten unserer Kunden ab. Zu diesen Endmärkten zählen Automobil, Enterprise Computing, Kommunikation, künstliche Intelligenz und Machine Learning, Unterhaltungselektronik und Industrie; sie unterliegen einer Reihe von Faktoren, darunter Akzeptanz und Absatz der Endprodukte, Wettbewerbsdruck, Lieferkettenprobleme und allgemeine Marktbedingungen.
„Supported by AI-driven automation, FlexGen reduces manual iteration providing expert-level NoC topologies, while reducing wire-length and power which are critical to advance node designs and becoming increasingly valued."
Gestützt auf KI-getriebene Automatisierung reduziert FlexGen manuelle Iterationen und liefert Network-on-Chip-Topologien auf Expertenniveau — bei geringerer Leitungslänge und geringerem Stromverbrauch, was für Designs auf modernsten Fertigungsprozessen entscheidend ist und zunehmend geschätzt wird.
„U.S. export regulations […] may limit or adversely impact our ability to license or support our products to entities in or doing business with certain advanced AI or “supercomputer” design companies, foundries and manufacturers of assemblies and components in China. As a result of these restrictions, our customers may experience changes to or delays in their design projects, and we may face challenges to maintain our revenue and/or our revenue may decrease."
US-Exportvorschriften […] können unsere Möglichkeiten einschränken oder beeinträchtigen, unsere Produkte an Unternehmen zu lizenzieren oder zu supporten, die zu bestimmten Entwicklern fortgeschrittener KI- oder „Supercomputer“-Chips, Auftragsfertigern sowie Herstellern von Baugruppen und Komponenten in China gehören oder mit ihnen Geschäfte machen. Infolge dieser Beschränkungen kann es bei unseren Kunden zu Änderungen oder Verzögerungen ihrer Design-Projekte kommen, und es kann uns schwerfallen, unseren Umsatz zu halten — beziehungsweise unser Umsatz kann sinken.
Filings Reviewed: 10-Q 2026-05-12 · 10-Q 2025-11-04 · 10-Q 2025-08-05 · 10-Q 2025-05-13 · 10-K 2026-02-12 · 10-K 2025-02-18
Rated on July 10, 2026 · How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.20 | – | 16 | 23.90 | -53.00 | -3 | -3 |
| 2025: Q1 | -0.20 | – | 17 | 27.70 | -49.10 | 3 | 3 |
| 2025: Q2 | -0.22 | – | 17 | 13.20 | -55.30 | -3 | -3 |
| 2025: Q3 | -0.21 | – | 17 | 18.30 | -51.60 | 3 | 3 |
| 2025: Q4 | -0.19 | – | 20 | 30.00 | -42.20 | 3 | 3 |
| 2026: Q1 | -0.17 | – | 23 | 38.70 | -34.70 | -7 | -7 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
About the Company
Arteris, Inc. bietet zusammen mit seinen Tochtergesellschaften Halbleiter-System-IP-Lösungen (geistiges Eigentum) in den USA, im übrigen Amerika, in China, Korea, im übrigen asiatisch-pazifischen Raum, in Europa und im Nahen Osten an.
| Employees | 353 |
|---|---|
| Headquarters | Campbell, CA |
| Website | arteris.com |
| IPO Date | 27. Oct 2021 |
| Next Earnings | 4. Aug 2026 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Karel Charles Janac | Chairman, CEO & President | 1959 |
| Nicholas Bryan Hawkins FCA | Executive VP & CFO | 1962 |
| Laurent R. Moll | Executive VP of Engineering & COO | 1972 |
| Paul L. Alpern | Executive VP, Chief Legal Officer & Corporate Secretary | 1965 |
| Michal Siwinski | EVP and Chief Product & Marketing Officer | – |
| Ken Way | Executive VP of Sales & Chief Customer Officer | – |
| Jolene Bishop | Executive VP & Chief Human Resources Officer | – |
| Evin Arici Kebebew | Corporate Controller | 1985 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 20, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.